Immunization News and Research

RSS

Scientists develop new system to display epitopes in mammal cells for immunization studies

A new paper in Biology Methods & Protocols, published by Oxford University Press, indicates that researchers in Germany have developed a new system to display epitopes in mammal cells for immunization studies.

12 Dec 2023

A step forward in vaccine technology: Exploring the effects of N1-methylpseudouridine in mRNA translation

Researchers explored how the incorporation of N1-methylpseudouridine (1-methylΨ) into mRNAs affects ribosomal frameshifting and the overall fidelity of mRNA translation.

7 Dec 2023

Promising candidate medication for preventing and reversing fentanyl-induced overdose

Researchers assessed CSX-1004, a monoclonal antibody (mAb), for its efficacy in reversing fentanyl overdose based on its high affinity for fentanyl, positive animal model results, and safe pharmacokinetic profile, positioning it as a potential solution in the opioid crisis.

7 Dec 2023

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

Researchers have discovered the novel mechanism that underlies a previously reported observation that infection by group A Streptococcus bacteria reduces the risk of later developing Type 1 diabetes.

5 Dec 2023

Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials

The safety, efficacy, and immunogenicity of a mRNA-based vaccine.

5 Dec 2023

American Psychological Association report highlights effective strategies to combat misinformation

A recent report from the American Psychological Association reviewed the available psychological science research to explore and combat health misinformation.

4 Dec 2023

RNA-based therapy shows promise for treating leukemia in animal models

Each year, about 13,000 people in Deutschland are diagnosed with leukemia, an umbrella term that encompasses various forms of blood cancer.

27 Nov 2023

Bivalent COVID-19 boosters offer stronger protection for seniors, Australian study reveals

Study compares the effectiveness of bivalent and monovalent booster vaccines against COVID-19 mortality in individuals aged 65 and older. It finds that bivalent boosters show higher vaccine effectiveness against COVID-19 mortality, particularly for the Omicron variant, compared to monovalent vaccines.

27 Nov 2023

Half-dose COVID-19 booster elicits similar immune response with fewer side effects

Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study.

23 Nov 2023

Empowering oncology research: Transmembrane proteins and cutting-edge production platforms

In this Interview, Dr. Fang-Yi Chu talks to NewsMed about the role of transmembrane proteins in targeting oncology research.

From Sino Biological Inc. 23 Nov 2023

How lawmakers in Texas and Florida undermine covid vaccination efforts

Katherine Wells wants to urge her Lubbock, Texas, community to get vaccinated against covid-19. "That could really save people from severe illness," said Wells, the city's public health director.

13 Nov 2023

Mucosal vaccine shows lasting defense against SARS-CoV-2 Omicron in primate study

In this groundbreaking study, researchers developed a mucosal adenoviral-vector vaccine, ChAd-SARS-CoV-2-S, which demonstrated sustained and robust immunity against a challenging Omicron variant in nonhuman primates, indicating a promising direction for durable COVID-19 protection strategies. Unlike traditional intramuscular vaccines, this mucosal vaccine elicited a comprehensive immune response, potentially paving the way for more effective and long-lasting COVID-19 vaccines.

9 Nov 2023

Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Bio Farma, a biotechnology company based in West Java, Indonesia, announced today that Bio Farma's Bio-TCV typhoid conjugate vaccine (TCV) was licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.

9 Nov 2023

A new RSV shot could help protect babies this winter — if they can get it in time

Emily Bendt was in her third trimester of pregnancy when she first heard the Centers for Disease Control and Prevention had approved a new shot for infants to protect them from the respiratory syncytial virus, or RSV.

9 Nov 2023

Study compares the immunogenicity and safety of two SARS-CoV-2 vaccines

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019. Since then, extensive efforts have been made to develop and evaluate vaccines to combat the virus.

8 Nov 2023

Immune imprinting: The crux of waning COVID-19 booster effectiveness against new variants

The study in Nature Microbiology reviews the concept of immune imprinting and its influence on antibody responses to SARS-CoV-2, highlighting challenges for COVID-19 booster vaccination efficacy against emerging variants. Researchers suggest that understanding immune imprinting is crucial for developing vaccines that elicit broad and lasting immune protection.

7 Nov 2023

Immunization News and Research

Scientists develop new system to display epitopes in mammal cells for immunization studies

A step forward in vaccine technology: Exploring the effects of N1-methylpseudouridine in mRNA translation

Promising candidate medication for preventing and reversing fentanyl-induced overdose

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials

American Psychological Association report highlights effective strategies to combat misinformation

RNA-based therapy shows promise for treating leukemia in animal models

Bivalent COVID-19 boosters offer stronger protection for seniors, Australian study reveals

Half-dose COVID-19 booster elicits similar immune response with fewer side effects

Empowering oncology research: Transmembrane proteins and cutting-edge production platforms

How lawmakers in Texas and Florida undermine covid vaccination efforts

Mucosal vaccine shows lasting defense against SARS-CoV-2 Omicron in primate study

Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

A new RSV shot could help protect babies this winter — if they can get it in time

Study compares the immunogenicity and safety of two SARS-CoV-2 vaccines

Immune imprinting: The crux of waning COVID-19 booster effectiveness against new variants

States reconsider religious exemptions for vaccinations in child care

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

A new era of vaccines leaves old questions about prices unanswered

From education to politics: a pan-European analysis of COVID-19 conspiracy theory influences

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News